VERACYTE, INC. Business Acquisition, Pro Forma Revenue
VERACYTE, INC. (VCYT) reported Business Acquisition, Pro Forma Revenue of $38.19 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-01.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2017-03-01
- VERACYTE, INC. business acquisition, pro forma revenue for the quarter ending 2014-12-31 was -$4.11M, a 160.06% decline year-over-year.
- VERACYTE, INC. business acquisition, pro forma revenue for the quarter ending 2014-09-30 was $9.84M, a 75.87% increase year-over-year.
- VERACYTE, INC. business acquisition, pro forma revenue for the quarter ending 2013-12-31 was $6.84M.
- VERACYTE, INC. business acquisition, pro forma revenue for the quarter ending 2013-09-30 was $5.59M.
- VERACYTE, INC. business acquisition, pro forma revenue for fiscal 2015 was $38.19M, a 74.51% increase from fiscal 2014.
- VERACYTE, INC. business acquisition, pro forma revenue for fiscal 2014 was $21.88M, a 0.00% change from fiscal 2013.
- VERACYTE, INC. business acquisition, pro forma revenue for fiscal 2013 was $21.88M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | $38.19M 10-K · filed 2017-03-01 | ||||
| 2014-12-31 | -$4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $5.73M derived: sum of 2 quarters · filed 2017-03-01 | $21.88M 10-K · filed 2017-03-01 | $38.19M 10-K · filed 2015-03-25 | |
| 2014-09-30 | $9.84M 10-Q · filed 2014-11-13 | $25.99M 10-Q · filed 2014-11-13 | |||
| 2013-12-31 | $6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $12.43M derived: sum of 2 quarters · filed 2016-03-14 | $21.88M 10-K · filed 2016-03-14 | ||
| 2013-09-30 | $5.59M 10-Q · filed 2014-11-13 | $15.05M 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |